Robert Alexander, Ph.D.
Robert joined Alta in 2005 as a Principal, and was promoted to Director in 2009. He currently serves on the board of directors of Allakos, Lumena Pharmaceuticals, SARcode Bioscience, Sonexa Therapeutics and ZS Pharma.
Prior to Alta, Robert was a Principal in MPM Capital’s BioEquities fund where he sourced opportunities and led due diligence efforts for both public and private investments. Robert joined MPM from Genentech where he worked in the Business Development group. At Genentech, his responsibilities included sourcing and screening product opportunities based on scientific merit and strategic fit, leading diligence teams and negotiating terms and definitive agreements.
Prior to joining Genentech, Robert was a post-doctoral fellow at Stanford University in the department of Pathology. He holds a Ph.D. in Immunology from the University of North Carolina and a Bachelor of Arts degree in Zoology from Miami University of Ohio.